184 related articles for article (PubMed ID: 19752087)
21. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells.
Kobune M; Kawano Y; Takahashi S; Takada K; Murase K; Iyama S; Sato T; Takimoto R; Niitsu Y; Kato J
Exp Hematol; 2008 Sep; 36(9):1121-31. PubMed ID: 18562079
[TBL] [Abstract][Full Text] [Related]
22. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.
Jetmore A; Plett PA; Tong X; Wolber FM; Breese R; Abonour R; Orschell-Traycoff CM; Srour EF
Blood; 2002 Mar; 99(5):1585-93. PubMed ID: 11861272
[TBL] [Abstract][Full Text] [Related]
23. Use of IL3 and chromatin-modifying reagents valproic acid and 5-aza-2'-deoxycytidine to affect mobilized peripheral blood CD34+ cell fate decisions.
Liu J; Samuel K; Turner ML; Gallagher RC
Vox Sang; 2014 Jul; 107(1):83-9. PubMed ID: 24460712
[TBL] [Abstract][Full Text] [Related]
24. Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.
Migliaccio AR; Martelli F; Verrucci M; Migliaccio G; Vannucchi AM; Ni H; Xu M; Jiang Y; Nakamoto B; Papayannopoulou T; Hoffman R
Exp Hematol; 2008 Feb; 36(2):158-71. PubMed ID: 18206727
[TBL] [Abstract][Full Text] [Related]
25. Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.
Wang X; Prakash S; Lu M; Tripodi J; Ye F; Najfeld V; Li Y; Schwartz M; Weinberg R; Roda P; Orazi A; Hoffman R
J Clin Invest; 2012 Nov; 122(11):3888-99. PubMed ID: 23023702
[TBL] [Abstract][Full Text] [Related]
26. The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells.
Leung KT; Chan KY; Ng PC; Lau TK; Chiu WM; Tsang KS; Li CK; Kong CK; Li K
Blood; 2011 Feb; 117(6):1840-50. PubMed ID: 21063023
[TBL] [Abstract][Full Text] [Related]
27. Short-term culture of umbilical cord blood-derived CD34 cells enhances engraftment into NOD/SCID mice through increased CXCR4 expression.
Ohno N; Kajiume T; Sera Y; Sato T; Kobayashi M
Stem Cells Dev; 2009 Oct; 18(8):1221-6. PubMed ID: 19113880
[TBL] [Abstract][Full Text] [Related]
28. Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity.
Abbà C; Campanelli R; Catarsi P; Villani L; Abbonante V; Sesta MA; Barosi G; Rosti V; Massa M
PLoS One; 2019; 14(8):e0220189. PubMed ID: 31369569
[TBL] [Abstract][Full Text] [Related]
29. The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cells.
Lu M; Xia L; Li Y; Wang X; Hoffman R
Blood; 2014 Jul; 124(5):771-9. PubMed ID: 24869939
[TBL] [Abstract][Full Text] [Related]
30. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
31. Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.
Hall KM; Horvath TL; Abonour R; Cornetta K; Srour EF
Exp Hematol; 2006 Apr; 34(4):433-42. PubMed ID: 16569590
[TBL] [Abstract][Full Text] [Related]
32. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
Hogan CJ; Shpall EJ; McNiece I; Keller G
Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions.
Lapidot T
Ann N Y Acad Sci; 2001 Jun; 938():83-95. PubMed ID: 11458529
[TBL] [Abstract][Full Text] [Related]
34. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
Pilarski LM; Belch AR
Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
[TBL] [Abstract][Full Text] [Related]
35. Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells.
Kawai T; Choi U; Liu PC; Whiting-Theobald NL; Linton GF; Malech HL
Stem Cells Dev; 2007 Jun; 16(3):361-70. PubMed ID: 17610366
[TBL] [Abstract][Full Text] [Related]
36. Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A.
Milhem M; Mahmud N; Lavelle D; Araki H; DeSimone J; Saunthararajah Y; Hoffman R
Blood; 2004 Jun; 103(11):4102-10. PubMed ID: 14976039
[TBL] [Abstract][Full Text] [Related]
37. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
Wang J; Kimura T; Asada R; Harada S; Yokota S; Kawamoto Y; Fujimura Y; Tsuji T; Ikehara S; Sonoda Y
Blood; 2003 Apr; 101(8):2924-31. PubMed ID: 12480697
[TBL] [Abstract][Full Text] [Related]
38. Immunoproteasome Genes Are Modulated in CD34
Di Rosa M; Giallongo C; Romano A; Tibullo D; Li Volti G; Musumeci G; Barbagallo I; Imbesi R; Castrogiovanni P; Palumbo GA
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331228
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC.
Bonig H; Priestley GV; Oehler V; Papayannopoulou T
Exp Hematol; 2007 Feb; 35(2):326-34. PubMed ID: 17258081
[TBL] [Abstract][Full Text] [Related]
40. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
